Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk | Zendy

Steven Boonen | Zendy; Jonathan D. Adachi | Zendy; Z. Man | Zendy; Steven R. Cummings | Zendy; Kurt Lippuner | Zendy; Ove Törring | Zendy; John C. Gallagher | Zendy; Jordi Farrerons | Zendy; A. Wang | Zendy; Nathalie Franchimont | Zendy; Javier San Martín | Zendy; Andreas Grauer | Zendy; Michael R. McClung | Zendy

AI Assistant Blog Pricing

Open Access

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk

Author(s) -

Steven Boonen,

Jonathan D. Adachi,

Z. Man,

Steven R. Cummings,

Kurt Lippuner,

Ove Törring,

John C. Gallagher,

Jordi Farrerons,

A. Wang,

Nathalie Franchimont,

Javier San Martín,

Andreas Grauer,

Michael R. McClung

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2010-2784

Subject(s) - denosumab , medicine , femoral neck , osteoporosis , placebo , incidence (geometry) , bone mineral , bone density , surgery , urology , physics , alternative medicine , pathology , optics

The FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis every 6 Months) trial showed denosumab significantly reduced the risk of fractures in postmenopausal women with osteoporosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog